Hypertension in 2017: Update in Treatment and Pharmaceutical Innovations.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612823666170927123454PMID 28969533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Formulation and Pharmacokinetics of Immediate-Release Oral Contraceptives

  2025cites this paper
• Association of living alone and living alone time with hypertension among Chinese men aged 80 years and older: a cohort study

  2024cites this paper
• Formulation and development of bilayer tablet containing irbesartan and metformin hydrochloride for diabetic hypertensive patients

  2024cites this paper
• Jellyfishes—Significant Marine Resources with Potential in the Wound-Healing Process: A Review

  2023cites this paper
• Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors.

  2020cites this paper
• Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives.

  2020cites this paper
• Polymeric Microparticles as Alternative Carriers for Antidiabetic Glibenclamide Drug

  2020cites this paper
• Recent trends on wound management: New therapeutic choices based on polymeric carriers

  2020cites this paper
• Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities

  2020cites this paper
• Assessment of blood pressure control in adult hypertensive patients in eastern Sudan

  2018cites this paper